Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
deals
3
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
biotech
clinical trials
gene therapy
hemophilia
indiana blog main
indiana top stories
new york blog main
new york top stories
rna interference
san diego blog main
san diego top stories
wisconsin blog main
wisconsin top stories
adeno-associated virus
alexandria venture investments
alexion pharmaceuticals
alnylam pharmaceutials
alnylam pharmaceuticals
altitude life science ventures
ambys medicines
american society of gene and cell therapy
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
arch venture partners
arrowhead pharmaceuticals
athenex
biomarin pharmaceutical
bluebird bio
boehringer ingelheim
boston
boulder/denver blog main
What
long
3
×
gene
help
therapy
abandoning
ago
aren’t
baggage
bio
companies
crude
cuts
cutting
deal
despite
developers
development
dicerna
drug
drugs
edge
effects
encoded
fda
free
gets
illumina’s
imminent
interference
lasting
limited
limits
medicare
medicine
medicines
moves
nabs
news
noteworthy
patients
Language
Current search:
long
×
deals
×
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More